Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-17

The COVID-19 pandemic severely disrupted early-phase pediatric cancer clinical trials in Spain, causing personnel shortages, recruitment halts, and reduced patient assessment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Purpose: The COVID-19 pandemic has forced healthcare stakeholders towards challenging decisions. We analyse the impact of the pandemic on the conduct of phase I-II trials for paediatric cancer during the first month of state of alarm in Spain. Methods: A questionnaire was sent to all five ITCC-accredited Spanish Paediatric Oncology Early-Phase Clinical Trial Units, including questions about impact on staff activities, recruitment, patient care, supply of investigational products and legal aspects. Results: All units suffered personnel shortages and difficulties in enrolling patients, treatment continuity or performing trial assessments. Monitoring activity was frequently postponed (73%), and 49% of on-going trials interrupted recruitment. Only two patients could be recruited during this period (75% reduction in the expected rate). Conclusions: The COVID-19 crisis has significantly impacted clinical research practice and access to innovation for children with cancer. Structural and functional changes are under way to better cope with the expected future restrictions.
Full text 182,518 characters · extracted from preprint-html · click to expand
Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP) | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Short Report Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP) Alba Rubio-San-Simon, Jaime Verdú-Amorós, Raquel Hladun, Antonio Juan Ribelles, and 8 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-28826/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 28 May, 2020 Read the published version in Clinical and Translational Oncology → Version 1 posted You are reading this latest preprint version Abstract Purpose: The COVID-19 pandemic has forced healthcare stakeholders towards challenging decisions. We analyse the impact of the pandemic on the conduct of phase I-II trials for paediatric cancer during the first month of state of alarm in Spain. Methods: A questionnaire was sent to all five ITCC-accredited Spanish Paediatric Oncology Early-Phase Clinical Trial Units, including questions about impact on staff activities, recruitment, patient care, supply of investigational products and legal aspects. Results: All units suffered personnel shortages and difficulties in enrolling patients, treatment continuity or performing trial assessments. Monitoring activity was frequently postponed (73%), and 49% of on-going trials interrupted recruitment. Only two patients could be recruited during this period (75% reduction in the expected rate). Conclusions: The COVID-19 crisis has significantly impacted clinical research practice and access to innovation for children with cancer. Structural and functional changes are under way to better cope with the expected future restrictions. Pediatrics Oncology Drug Discovery, Design, & Development COVID-19 clinical trials clinical research paediatric haematology and oncology development policy Figures Figure 1 Purpose The COVID19 pandemic has affected more than 3 million people worldwide and 25,000 have died in Spain as of 2nd May 2020[1] and healthcare stakeholders have taken challenging decisions to safeguard public health. In Spain, on March 14th, the government declared the state of alarm[2]. As a consequence, the Spanish healthcare system has suffered unprecedented adjustments to prioritize resources for the fight against COVID-19[3]. Outpatient follow-up and elective procedures have been cancelled and healthcare providers reallocated to assist patients with COVID-19. Although SARS-CoV-2 is suspected to infect children milder than adults[4], adjustment of healthcare facilities has been established also for them[5,6]. The countermeasures adopted by the authorities can impact hardly in clinical research, which often is perceived as a “desirable but not essential” activity. Actions undertaken can affect the conduct of clinical trials in many ways (e.g. completion of trial assessments, visits, provision of investigational medicinal products (IMPs)). Furthermore, pharmaceutical companies may refocus resources into areas related to COVID-19 (e.g. vaccines or antiviral drugs), thus affecting other research areas. This situation forces sponsors, investigators and patients to adapt. The European Medicines Agency and the Spanish Agency of Medicines and Medical Devices have issued guidelines on the management of clinical trial activities[7,8] Both are aligned in the intention to guarantee trial activity, patient safety and action traceability. However, all parties (i.e. healthcare authorities, hospitals, regulators, sponsors) have implemented measures differently depending on the impact of the pandemic in their regions and their capacity to adapt, although not all coordinated nor evidence-based. Cancer research is particularly challenging because patients are remarkably vulnerable: their baseline condition needs close surveillance and delays in diagnosis or treatment are potentially fatal[9]; in parallel, cancer patients are at increased risk for severe COVID-19 disease[10-12] We evaluated the impact of the COVID-19 pandemic on the early-phase clinical trial activity in paediatric oncology during the first month of state of alarm in Spain (14th March-12th/April/2020). Methods In Spain, the Innovative Therapies for Children with Cancer consortium (ITCC), an international scientific organisation dedicated to early drug development for childhood cancers in 56 centres from 14 European countries, has accredited five paediatric cancer centres to deliver early phase clinical trials[13]. All five centres were contacted and sent a 93-item questionnaire between 13th-19th/April/2020 investigating the impact of the pandemic on actively recruiting phase I-II clinical trials in solid and haematological paediatric malignancies and on molecular cancer platforms (Appendix I). Descriptive statistics of the survey are provided. Results Impact on staff All units suffered shortages on on-site staff in all professional strata (Table I). The median decrease in personnel was 59% (range 33-100). Main causes were: institutional contingency policies (88%), COVID- 19-infected workers (7%) and relocation to other hospital areas (5%). All units managed to perform remote data entry although two were not fully equipped for and had difficulties to perform their activities. Impact on on-site activities performed by the sponsors Seventy percent (7/10) planned site initiation visits (SIV) were postponed and 30% (n=3) were performed remotely, all as per decision of the sponsor. Seventy three percent (36/49) planned monitoring visits (MV) were postponed and 27% (n=13) were performed remotely, mostly due to institutional decision (70%). Impact on recruitment The median number of studies that stopped recruitment per site was 6 (range 2-6), a 49% on average (SD 32.5) of actively recruiting studies. The decision to stop was taken per sponsor (47%) or per local institutions (53%). One unit interrupted recruitment in all trials (n=18) following institutional decision. During this period only two new patients were enrolled across the whole of Spain, 75% less than the monthly average in 2019 (n=8). Impact on organization of patient care All units continued on-site patient care with limitations. Two units had restrictions to perform assessments due to local prevention strategies. Out of 143 planned patient visits, 15 (10%) had to be rescheduled. Most were conducted on-site (77%, 110), while 14% (20) were conducted by phone and 9% (13) in other hospitals closer to family home. Only one patient experienced treatment delay (parents’ decision). Seven patients that were potentially eligible could not be enrolled. Of those, four received non-trial treatments and three are on standby. The reasons for not enrolling were: recruitment interrupted by sponsor (n=3) and not considered safe to be included by investigators (n=4) Impact on supply of investigational medicinal product and research devices Provision of IMPs and research devices, as well as shipment of research samples, were uniformly warranted. For six trials, two units were able to ship IMPs to patients’ homes or to local hospitals. Three units provided larger amounts of trial medications to patients to minimise hospital visits. Impact on legal and regulatory aspects The completion of three planned contracts was delayed. All units have been provided with contingency plans by sponsors and have also created individual plans for the management of COVID-19 related issues. Future perspective All investigators foresee a lower recruitment in 2020 compared to 2019. Most are planning changes over the next months to promote homeworking and remote SIVs/MVs. All investigators believe that this crisis will make units better prepared for future crises. Following the analysis of this survey results and the collected expert consensus, we propose a set of recommendations to preserve patient safety, scientific integrity and research value (Figure 1). Conclusions This study reveals that paediatric cancer clinical research has been significantly impacted by the COVID- 19 pandemic. Shortage of personnel has been a major issue in all units, as a consequence of contingency plans restricting on-site work. While physicians and nurses’ activities have been severely compromised as their activities are essentially patient-centred, it may have less impact on other professional strata such as study coordinators or data-managers, provided that they have appropriate means to perform their work remotely. Unfortunately, this was not the case for all institutions. Providing homeworking solutions is essential under the perspective of sustained restrictions over the next months. Although redeployment of staff to other areas in the fight against COVID-19 is necessary, it has an undeniable impact on areas with highly specialized, multidisciplinary activities, as is clinical research. Our study shows drastic suspension/delays of SIVs and MVs. Delays in SIV are understandable decisions because of the inherent complexity of early-phase studies but they need to be rescheduled as soon as possible. However, MVs are key to ensure safety and data quality of on-going trials, and hence it is necessary that sponsors implement alternative mechanisms to resume it in collaboration with the sites while preserving patient data protection (e.g. remote access to electronic medical records with regular contacts with the study coordinators). All units have experienced restrictions in treatment delivery or ability to conduct trial assessments. Nevertheless, all units have implemented strategies to mitigate these risks while delivering treatment to the patients, complying with trial regulations and in agreement with sponsors. The outbreak is expected to increase protocol deviations, highlighting the need for a fluid communication between sites, ethics committees, sponsors and regulators. Regulators should take a sensible approach when reviewing these deviations, especially when the trial participant’s best interest has been taken into account and no additional risk has been posed[8]. In our study, only one patient had his treatment delayed due to family’s fears of travelling. While patients and caregivers are advised to restrict hospital visits, they may delay medical consultation when facing adverse events during a trial. Cortiula et al.[9] highlighted the negative implications of excessive focus on COVID-19 and of overshadowing other aspects of clinical practice, especially in cancer care. Only two patients could be recruited in this period, a 75% reduction in the expected recruitment rate, while seven potentially eligible patients could not be recruited. Clinical trials are most of the times the unique way to provide access to new drugs with significant patient benefit (e.g. TRK inhibitors for TRK -fusion cancers[14]), or at the very least, to innovative therapies to children with no curative options. Whereas COVID-19 has a low mortality in children[4], more than 90% of children with relapsed and refractory cancers will continue to die and hence access to novel therapies needs to be assured. Moreover, the stalling process on experimental medicines will extend the already lengthy marketing process and have an impact on the companies’ market value[15]. Therefore, long-term consequences of the pandemic on clinical research remain unpredictable. Although there are multiple publications about generic emergency preparedness in health settings, there is minimal information focusing on clinical trial sites[16,17] and we provide recommendations on this respect (Figure 1). All consulted investigators conclude that this crisis will make trial units better prepared for future emergencies and they are planning changes in their organization. Our results show that the COVID-19 crisis has had a major impact on conducting paediatric oncology research. Our conclusions will hopefully help investigators, sponsors and authorities to address the issues derived from this pandemic and facilitate the construction of a consensus strategy for future crises. This would allow for maintaining high-quality care, standardizing procedures and prioritizing an efficient use of resources, to ensure safe access to therapies in the context of clinical trials. Declarations Funding: There was no funding for this study Conflicts of interest: F. Bautista had a consultant or advisory role for Bayer, Amgen, Sanofi and EusaPharma, received honoraria for speaking at symposia from Amgen and Jazz Pharmaceuticals and support for attending symposia from Takeda, EusaPharma, Shire and Jazz Pharmaceuticals. L. Moreno had a consulting or advisory role for Novartis, AstraZeneca, Roche Genentech, Bayer, Amgen, MundiPharma. He received honoraria from Celgene and Novartis for educational events and travel expenses from MundiPharma, Celgene, Amgen. L Moreno is a member of the Executive Committee of SIOPEN, non-profit organization that receives royalties for the sales of dinutuximab beta. A.Cañete had a consulting or advisory role for Eusa Pharma and Bayer. She received honoraria from Usa Pharma for educational events and travel expenses. A. Canete is a member of the Executive Committee of SIOPEN, non-profit organization that receives royalties for the sales of dinutuximab beta. The rest of the authors declare that they have no conflict of interest. Ethics/Consent: Since the study does not include humans and it is just an epidemiological study based in questionnaires responses, it was not necessary to ask for ethics committee approval or participants’ consent. References Coronavirus disease (COVID-19) Situation in numbers (by WHO Region) [Internet]. [cited 2020 May 5]. Available from: https ://www. who .int/docs/default-source/coronaviruse/situation- reports/20200504-covid-19-sitrep-105.pdf?sfvrsn=4cdda8af_2 BOE.es - Documento consolidado BOE-A-2020-3692 [Internet]. [cited 2020 Apr 18]. Available from: https ://www. bo e.es/eli/es/rd/2 0 20/03/14/463/con Infection prevention and control and preparedness for COVID-19 in healthcare settings - second update [Internet]. [cited 2020 Apr 18]. Available from: https ://www. ecd europa.eu/en/publications-data/infection-prevention-and-control-and- preparedness-covid-19-healthcare-settings Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World Journal of Pediatrics. 2020. Calvo C, García López-Hortelano M, de Carlos Vicente JC, Vázquez Martínez JL, Ramos JT, Baquero-Artigao F, et al. Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). An Pediatría. 2020; Medidas excepcionales aplicables a los ensayos clínicos para gestionar los problemas derivados de la emergencia por COVID-19 - Agencia Española de Medicamentos y Productos Sanitarios [Internet]. [cited 2020 May 5]. Available from: https ://www. aem gob.es/informa/notasinformativas/medicamentosusohumano-3/2020- medicamentosusohumano-3/medidas-excepcionales-aplicables-a-los-ensayos-clinicos-para- gestionar-los-problemas-derivados-de-la-emergencia-por-covid-19/ Guidance on the management of clinical trials during the covid-19 (coronavirus) pandemic [Internet]. [cited 2020 May 5]. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol- 10/guidanceclinicaltrials_covid19_en.pdf Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020; Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology 2020. Chen Z, Xiong H, Li JX, Li H, Tao F, Yang YT, et al. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report]. Zhonghua Xue Ye Xue Za Zhi. 2020; Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez-Galindo C, Pritchard-Jones K. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020; Zwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, et al. The role of the “innovative therapies for children with cancer” (ITCC) European consortium. Cancer Treatment Reviews. 2010. Correction: Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study (The Lancet Oncology (2018) 19(5) (705– 714) (S1470204518301190) (10.1016/S1470-2045(18)30119-0)). The Lancet Oncology 2018. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve RD productivity: The pharmaceutical industry’s grand challenge. Nature Reviews Drug Discovery 2010. McDuffie R, Summerson J, Reilly P, Blackwell C, Goff D, Kimel AR, et al. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial and Hurricane Katrina: Lessons for managing clinical trials during and after a natural disaster. Contemp Clin Trials. 2008; Lunt H, Heenan H. Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events. Contemp Clin Trials Commun. 2019; Tables Supplementary Files Appendix1.pdf Cite Share Download PDF Status: Published Journal Publication published 28 May, 2020 Read the published version in Clinical and Translational Oncology → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-28826","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Short Report","associatedPublications":[],"authors":[{"id":574337,"identity":"5d74875a-fe03-4b08-8fcf-7289a41c795b","order_by":1,"name":"Alba Rubio-San-Simon","email":"","orcid":"https://orcid.org/0000-0001-6426-7423","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alba","middleName":"","lastName":"Rubio-San-Simon","suffix":""},{"id":574368,"identity":"ae6d79c1-f183-4fc8-9855-674f1f2247f0","order_by":2,"name":"Jaime Verdú-Amorós","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Jaime","middleName":"","lastName":"Verdú-Amorós","suffix":""},{"id":574369,"identity":"f6b606dd-f0ab-40f0-9af9-779c6b339e57","order_by":3,"name":"Raquel Hladun","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitari Vall d´Hebron, Barcelona, Spain ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Raquel","middleName":"","lastName":"Hladun","suffix":""},{"id":574370,"identity":"3ac59913-c8d5-4080-979d-c39835280095","order_by":4,"name":"Antonio Juan Ribelles","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Antonio","middleName":"Juan","lastName":"Ribelles","suffix":""},{"id":574371,"identity":"22466fb1-df7f-4f12-b30e-45cdcd3b69d6","order_by":5,"name":"Mari Molero ","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Mari","middleName":"","lastName":"Molero","suffix":""},{"id":574372,"identity":"87f1b399-af11-4d99-8b57-92d404df9899","order_by":6,"name":"Pilar Guerra-García","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario La Paz, Madrid, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Pilar","middleName":"","lastName":"Guerra-García","suffix":""},{"id":574373,"identity":"c4ca6850-90ce-476e-ba89-b28388d93125","order_by":7,"name":"Antonio Pérez-Martínez","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario La Paz, Madrid, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Antonio","middleName":"","lastName":"Pérez-Martínez","suffix":""},{"id":574386,"identity":"f8b85e2e-f50c-416f-81d8-421463de93be","order_by":8,"name":"Alicia Castañeda","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alicia","middleName":"","lastName":"Castañeda","suffix":""},{"id":574387,"identity":"6867ef01-688a-4ac8-b407-fbde1b2a181e","order_by":9,"name":"Adela Cañete","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Adela","middleName":"","lastName":"Cañete","suffix":""},{"id":574400,"identity":"044089be-1618-4536-96f1-7560249aa08e","order_by":10,"name":"Teresa de Rojas ","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Teresa","middleName":"","lastName":"de Rojas","suffix":""},{"id":574401,"identity":"b81855a3-2238-4f18-a5de-087023f0d24d","order_by":11,"name":"Lucas Moreno ","email":"","orcid":"","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitari Vall d´Hebron, Barcelona, Spain ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Lucas","middleName":"","lastName":"Moreno","suffix":""},{"id":574412,"identity":"7a84c124-5390-4ef9-a4db-156ab75f6e29","order_by":12,"name":"Francisco Bautista ","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0002-0421-8862","institution":"Division of Paediatric Haematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Francisco","middleName":"","lastName":"Bautista","suffix":""}],"badges":[],"createdAt":"2020-05-14 08:47:14","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-28826/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-28826/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1007/s12094-020-02399-3","type":"published","date":"2020-05-29T02:40:45+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":1192170,"identity":"850967d6-206e-45ac-a4c5-61630203b62f","added_by":"auto","created_at":"2020-05-28 02:53:52","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":123300,"visible":true,"origin":"","legend":"Practical suggestions for cancer clinical trials paediatric participants care during the COVID-19 outbreak","description":"","filename":"1.png","url":"https://assets-eu.researchsquare.com/files/rs-28826/v1/1.png"},{"id":13532916,"identity":"48c370f0-2616-461b-9af2-ff115c4b2a98","added_by":"auto","created_at":"2021-09-17 01:18:55","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":441223,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-28826/v1/be068c2a-5b9c-43c4-83bf-759f78b19e42.pdf"},{"id":1192171,"identity":"638f8994-8f3a-4d88-8c77-414334d0adf4","added_by":"auto","created_at":"2020-05-28 02:53:52","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":192008,"visible":true,"origin":"","legend":"","description":"","filename":"Appendix1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-28826/v1/Appendix1.pdf"}],"financialInterests":"","formattedTitle":"\u003cp\u003eChallenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)\u003c/p\u003e","fulltext":[{"header":"Purpose","content":"\u003cp\u003eThe COVID19 pandemic has affected more than 3 million people worldwide and 25,000 have died in Spain as of 2nd May 2020[1] and healthcare stakeholders have taken challenging decisions to safeguard public health. In Spain, on March 14th, the government declared the state of alarm[2]. As a consequence, the Spanish healthcare system has suffered unprecedented adjustments to prioritize resources for the fight against COVID-19[3]. Outpatient follow-up and elective procedures have been cancelled and healthcare providers reallocated to assist patients with COVID-19.\u003c/p\u003e\n\u003cp\u003eAlthough SARS-CoV-2 is suspected to infect children milder than adults[4], adjustment of healthcare facilities has been established also for them[5,6].\u003c/p\u003e\n\u003cp\u003eThe countermeasures adopted by the authorities can impact hardly in clinical research, which often is perceived as a \u0026ldquo;desirable but not essential\u0026rdquo; activity. Actions undertaken can affect the conduct of clinical trials in many ways (e.g. completion of trial assessments, visits, provision of investigational medicinal products (IMPs)). Furthermore, pharmaceutical companies may refocus resources into areas related to COVID-19 (e.g. vaccines or antiviral drugs), thus affecting other research areas.\u003c/p\u003e\n\u003cp\u003eThis situation forces sponsors, investigators and patients to adapt. The European Medicines Agency and the Spanish Agency of Medicines and Medical Devices have issued guidelines on the management of clinical trial activities[7,8] Both are aligned in the intention to guarantee trial activity, patient safety and action traceability. However, all parties (i.e. healthcare authorities, hospitals, regulators, sponsors) have implemented measures differently depending on the impact of the pandemic in their regions and their capacity to adapt, although not all coordinated nor evidence-based.\u003c/p\u003e\n\u003cp\u003eCancer research is particularly challenging because patients are remarkably vulnerable: their baseline condition needs close surveillance and delays in diagnosis or treatment are potentially fatal[9]; in parallel, cancer patients are at increased risk for severe COVID-19 disease[10-12]\u003c/p\u003e\n\u003cp\u003eWe evaluated the impact of the COVID-19 pandemic on the early-phase clinical trial activity in paediatric oncology during the first month of state of alarm in Spain (14th March-12th/April/2020).\u003c/p\u003e"},{"header":"Methods","content":"\u003cp\u003eIn Spain, the Innovative Therapies for Children with Cancer consortium (ITCC), an international scientific organisation dedicated to early drug development for childhood cancers in 56 centres from 14 European countries, has accredited five paediatric cancer centres to deliver early phase clinical trials[13]. All five centres were contacted and sent a 93-item questionnaire between 13th-19th/April/2020 investigating the impact of the pandemic on actively recruiting phase I-II clinical trials in solid and haematological paediatric malignancies and on molecular cancer platforms (Appendix I).\u003c/p\u003e\n\u003cp\u003eDescriptive statistics of the survey are provided.\u003c/p\u003e"},{"header":"Results","content":"\u003ch2\u003eImpact on staff\u003c/h2\u003e\n\u003cp\u003eAll units suffered shortages on on-site staff in all professional strata (Table I). The median decrease in personnel was 59% (range 33-100). Main causes were: institutional contingency policies (88%), COVID- 19-infected workers (7%) and relocation to other hospital areas (5%).\u003c/p\u003e\n\u003cp\u003eAll units managed to perform remote data entry although two were not fully equipped for and had difficulties to perform their activities.\u003c/p\u003e\n\u003ch2\u003eImpact on on-site activities performed by the sponsors\u003c/h2\u003e\n\u003cp\u003eSeventy percent (7/10) planned site initiation visits (SIV) were postponed and 30% (n=3) were performed remotely, all as per decision of the sponsor.\u003c/p\u003e\n\u003cp\u003eSeventy three percent (36/49) planned monitoring visits (MV) were postponed and 27% (n=13) were performed remotely, mostly due to institutional decision (70%).\u003c/p\u003e\n\u003ch2\u003eImpact on recruitment\u003c/h2\u003e\n\u003cp\u003eThe median number of studies that stopped recruitment per site was 6 (range 2-6), a 49% on average (SD 32.5) of actively recruiting studies. The decision to stop was taken per sponsor (47%) or per local institutions (53%). One unit interrupted recruitment in all trials (n=18) following institutional decision. During this period only two new patients were enrolled across the whole of Spain, 75% less than the monthly average in 2019 (n=8).\u003c/p\u003e\n\u003ch2\u003eImpact on organization of patient care\u003c/h2\u003e\n\u003cp\u003eAll units continued on-site patient care with limitations. Two units had restrictions to perform assessments due to local prevention strategies.\u003c/p\u003e\n\u003cp\u003eOut of 143 planned patient visits, 15 (10%) had to be rescheduled. Most were conducted on-site (77%, 110), while 14% (20) were conducted by phone and 9% (13) in other hospitals closer to family home. Only one patient experienced treatment delay (parents\u0026rsquo; decision).\u003c/p\u003e\n\u003cp\u003eSeven patients that were potentially eligible could not be enrolled. Of those, four received non-trial treatments and three are on standby. The reasons for not enrolling were: recruitment interrupted by sponsor (n=3) and not considered safe to be included by investigators (n=4)\u003c/p\u003e\n\u003ch2\u003eImpact on supply of investigational medicinal product and research devices\u003c/h2\u003e\n\u003cp\u003eProvision of IMPs and research devices, as well as shipment of research samples, were uniformly warranted. For six trials, two units were able to ship IMPs to patients\u0026rsquo; homes or to local hospitals. Three units provided larger amounts of trial medications to patients to minimise hospital visits.\u003c/p\u003e\n\u003ch2\u003eImpact on legal and regulatory aspects\u003c/h2\u003e\n\u003cp\u003eThe completion of three planned contracts was delayed. All units have been provided with contingency plans by sponsors and have also created individual plans for the management of COVID-19 related issues.\u003c/p\u003e\n\u003ch2\u003eFuture perspective\u003c/h2\u003e\n\u003cp\u003eAll investigators foresee a lower recruitment in 2020 compared to 2019. Most are planning changes over the next months to promote homeworking and remote SIVs/MVs. All investigators believe that this crisis will make units better prepared for future crises.\u003c/p\u003e\n\u003cp\u003eFollowing the analysis of this survey results and the collected expert consensus, we propose a set of recommendations to preserve patient safety, scientific integrity and research value (Figure 1).\u003c/p\u003e"},{"header":"Conclusions","content":"\u003cp\u003eThis study reveals that paediatric cancer clinical research has been significantly impacted by the COVID- 19 pandemic.\u003c/p\u003e\n\u003cp\u003eShortage of personnel has been a major issue in all units, as a consequence of contingency plans restricting on-site work. While physicians and nurses\u0026rsquo; activities have been severely compromised as their activities are essentially patient-centred, it may have less impact on other professional strata such as study coordinators or data-managers, provided that they have appropriate means to perform their work remotely. Unfortunately, this was not the case for all institutions. Providing homeworking solutions is essential under the perspective of sustained restrictions over the next months. Although redeployment of staff to other areas in the fight against COVID-19 is necessary, it has an undeniable impact on areas with highly specialized, multidisciplinary activities, as is clinical research.\u003c/p\u003e\n\u003cp\u003eOur study shows drastic suspension/delays of SIVs and MVs. Delays in SIV are understandable decisions because of the inherent complexity of early-phase studies but they need to be rescheduled as soon as possible. However, MVs are key to ensure safety and data quality of on-going trials, and hence it is necessary that sponsors implement alternative mechanisms to resume it in collaboration with the sites while preserving patient data protection (e.g. remote access to electronic medical records with regular contacts with the study coordinators).\u003c/p\u003e\n\u003cp\u003eAll units have experienced restrictions in treatment delivery or ability to conduct trial assessments. Nevertheless, all units have implemented strategies to mitigate these risks while delivering treatment to the patients, complying with trial regulations and in agreement with sponsors. The outbreak is expected to increase protocol deviations, highlighting the need for a fluid communication between sites, ethics committees, sponsors and regulators. Regulators should take a sensible approach when reviewing these deviations, especially when the trial participant\u0026rsquo;s best interest has been taken into account and no additional risk has been posed[8].\u003c/p\u003e\n\u003cp\u003eIn our study, only one patient had his treatment delayed due to family\u0026rsquo;s fears of travelling. While patients and caregivers are advised to restrict hospital visits, they may delay medical consultation when facing adverse events during a trial. Cortiula et al.[9] highlighted the negative implications of excessive focus on COVID-19 and of overshadowing other aspects of clinical practice, especially in cancer care.\u003c/p\u003e\n\u003cp\u003eOnly two patients could be recruited in this period, a 75% reduction in the expected recruitment rate, while seven potentially eligible patients could not be recruited. Clinical trials are most of the times the unique way to provide access to new drugs with significant patient benefit (e.g. TRK inhibitors for \u003cem\u003eTRK\u003c/em\u003e-fusion cancers[14]), or at the very least, to innovative therapies to children with no curative options. Whereas COVID-19 has a low mortality in children[4], more than 90% of children with relapsed and refractory cancers will continue to die and hence access to novel therapies needs to be assured. Moreover, the stalling process on experimental medicines will extend the already lengthy marketing process and have an impact on the companies\u0026rsquo; market value[15]. Therefore, long-term consequences of the pandemic on clinical research remain unpredictable.\u003c/p\u003e\n\u003cp\u003eAlthough there are multiple publications about generic emergency preparedness in health settings, there is minimal information focusing on clinical trial sites[16,17] and we provide recommendations on this respect (Figure 1).\u003c/p\u003e\n\u003cp\u003eAll consulted investigators conclude that this crisis will make trial units better prepared for future emergencies and they are planning changes in their organization.\u003c/p\u003e\n\u003cp\u003eOur results show that the COVID-19 crisis has had a major impact on conducting paediatric oncology research. Our conclusions will hopefully help investigators, sponsors and authorities to address the issues derived from this pandemic and facilitate the construction of a consensus strategy for future crises. This would allow for maintaining high-quality care, standardizing procedures and prioritizing an efficient use of resources, to ensure safe access to therapies in the context of clinical trials.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eFunding:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThere was no funding for this study\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflicts of interest:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eF. Bautista had a consultant or advisory role for Bayer, Amgen, Sanofi and EusaPharma, received honoraria for speaking at symposia from Amgen and Jazz Pharmaceuticals and support for attending symposia from Takeda, EusaPharma, Shire and Jazz Pharmaceuticals.\u003c/p\u003e\n\u003cp\u003eL. Moreno had a consulting or advisory role for Novartis, AstraZeneca, Roche Genentech, Bayer, Amgen, MundiPharma. He received honoraria from Celgene and Novartis for educational events and travel expenses from MundiPharma, Celgene, Amgen. L Moreno is a member of the Executive Committee of SIOPEN, non-profit organization that receives royalties for the sales of dinutuximab beta. A.Ca\u0026ntilde;ete had a consulting or advisory role for Eusa Pharma and Bayer. She received honoraria from Usa Pharma for educational events and travel expenses.\u003c/p\u003e\n\u003cp\u003eA. Canete is a member of the Executive Committee of SIOPEN, non-profit organization that receives royalties for the sales of dinutuximab beta.\u003c/p\u003e\n\u003cp\u003eThe rest of the authors declare that they have no conflict of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics/Consent:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSince the study does not include humans and it is just an epidemiological study based in questionnaires responses, it was not necessary to ask for ethics committee approval or participants\u0026rsquo; consent.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eCoronavirus disease (COVID-19) Situation in numbers (by WHO Region) [Internet]. [cited 2020 May 5]. Available from: https\u003ca href=\"http://www.who.int/docs/default-source/coronaviruse/situation-\"\u003e://www.\u003c/a\u003ewho\u003ca href=\"http://www.who.int/docs/default-source/coronaviruse/situation-\"\u003e.int/docs/default-source/coronaviruse/situation-\u003c/a\u003e reports/20200504-covid-19-sitrep-105.pdf?sfvrsn=4cdda8af_2\u003c/li\u003e\n\u003cli\u003eBOE.es - Documento consolidado BOE-A-2020-3692 [Internet]. [cited 2020 Apr 18]. Available from: https\u003ca href=\"http://www.boe.es/eli/es/rd/2020/03/14/463/con\"\u003e://www.\u003c/a\u003ebo\u003ca href=\"http://www.boe.es/eli/es/rd/2020/03/14/463/con\"\u003ee.es/eli/es/rd/2\u003c/a\u003e0\u003ca href=\"http://www.boe.es/eli/es/rd/2020/03/14/463/con\"\u003e20/03/14/463/con\u003c/a\u003e\u003c/li\u003e\n\u003cli\u003eInfection prevention and control and preparedness for COVID-19 in healthcare settings - second update [Internet]. [cited 2020 Apr 18]. Available from: https\u003ca href=\"http://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-and-\"\u003e://www.\u003c/a\u003eecd\u003ca href=\"http://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-and-\"\u003eeuropa.eu/en/publications-data/infection-prevention-and-control-and-\u003c/a\u003e preparedness-covid-19-healthcare-settings\u003c/li\u003e\n\u003cli\u003eLudvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;\u003c/li\u003e\n\u003cli\u003eShen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u0026rsquo; consensus statement. World Journal of Pediatrics. 2020.\u003c/li\u003e\n\u003cli\u003eCalvo C, Garc\u0026iacute;a L\u0026oacute;pez-Hortelano M, de Carlos Vicente JC, V\u0026aacute;zquez Mart\u0026iacute;nez JL, Ramos JT, Baquero-Artigao F, et al. Recomendaciones sobre el manejo cl\u0026iacute;nico de la infecci\u0026oacute;n por el \u0026laquo;nuevo coronavirus\u0026raquo; SARS-CoV2. Grupo de trabajo de la Asociaci\u0026oacute;n Espa\u0026ntilde;ola de Pediatr\u0026iacute;a (AEP). An Pediatr\u0026iacute;a. 2020;\u003c/li\u003e\n\u003cli\u003eMedidas excepcionales aplicables a los ensayos cl\u0026iacute;nicos para gestionar los problemas derivados de la emergencia por COVID-19 - Agencia Espa\u0026ntilde;ola de Medicamentos y Productos Sanitarios [Internet]. [cited 2020 May 5]. Available from: https\u003ca href=\"http://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-\"\u003e://www.\u003c/a\u003eaem\u003ca href=\"http://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-\"\u003egob.es/informa/notasinformativas/medicamentosusohumano-3/2020-\u003c/a\u003e medicamentosusohumano-3/medidas-excepcionales-aplicables-a-los-ensayos-clinicos-para- gestionar-los-problemas-derivados-de-la-emergencia-por-covid-19/\u003c/li\u003e\n\u003cli\u003eGuidance on the management of clinical trials during the covid-19 (coronavirus) pandemic [Internet]. [cited 2020 May 5]. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol- 10/guidanceclinicaltrials_covid19_en.pdf\u003c/li\u003e\n\u003cli\u003eCortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020;\u003c/li\u003e\n\u003cli\u003eLiang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology 2020.\u003c/li\u003e\n\u003cli\u003eChen Z, Xiong H, Li JX, Li H, Tao F, Yang YT, et al. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report]. Zhonghua Xue Ye Xue Za Zhi. 2020;\u003c/li\u003e\n\u003c/ol\u003e\n\u003col start=\"12\"\u003e\n\u003cli\u003eBouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez-Galindo C, Pritchard-Jones K. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020;\u003c/li\u003e\n\u003cli\u003eZwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, et al. The role of the \u0026ldquo;innovative therapies for children with cancer\u0026rdquo; (ITCC) European consortium. Cancer Treatment Reviews. 2010.\u003c/li\u003e\n\u003cli\u003eCorrection: Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study (The Lancet Oncology (2018) 19(5) (705\u0026ndash; 714) (S1470204518301190) (10.1016/S1470-2045(18)30119-0)). The Lancet Oncology 2018.\u003c/li\u003e\n\u003cli\u003ePaul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve RD productivity: The pharmaceutical industry\u0026rsquo;s grand challenge. Nature Reviews Drug Discovery 2010.\u003c/li\u003e\n\u003cli\u003eMcDuffie R, Summerson J, Reilly P, Blackwell C, Goff D, Kimel AR, et al. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial and Hurricane Katrina: Lessons for managing clinical trials during and after a natural disaster. Contemp Clin Trials. 2008;\u003c/li\u003e\n\u003cli\u003eLunt H, Heenan H. Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events. Contemp Clin Trials Commun. 2019;\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Tables","content":"\u003cp\u003e\u003cimg src=\"data:image/png;base64,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\" style=\"width: 523px;\"\u003e\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"COVID-19, clinical trials, clinical research, paediatric haematology and oncology, development policy ","lastPublishedDoi":"10.21203/rs.3.rs-28826/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-28826/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003ePurpose: The COVID-19 pandemic has forced healthcare stakeholders towards challenging decisions. We analyse the impact of the pandemic on the conduct of phase I-II trials for paediatric cancer during the first month of state of alarm in Spain.\u003c/p\u003e\u003cp\u003eMethods: A questionnaire was sent to all five ITCC-accredited Spanish Paediatric Oncology Early-Phase Clinical Trial Units, including questions about impact on staff activities, recruitment, patient care, supply of investigational products and legal aspects.\u003c/p\u003e\u003cp\u003eResults: All units suffered personnel shortages and difficulties in enrolling patients, treatment continuity or performing trial assessments. Monitoring activity was frequently postponed (73%), and 49% of on-going trials interrupted recruitment. Only two patients could be recruited during this period (75% reduction in the expected rate).\u003c/p\u003e\u003cp\u003eConclusions: The COVID-19 crisis has significantly impacted clinical research practice and access to innovation for children with cancer. Structural and functional changes are under way to better cope with the expected future restrictions.\u003c/p\u003e","manuscriptTitle":"Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2020-05-27 21:42:56","doi":"10.21203/rs.3.rs-28826/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"c1c57592-0dc8-4805-b7a8-ddbdb0aeb8b9","owner":[],"postedDate":"May 27th, 2020","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":100192,"name":"Pediatrics"},{"id":100193,"name":"Oncology"},{"id":100194,"name":"Drug Discovery, Design, \u0026 Development"}],"tags":[],"updatedAt":"2021-07-22T02:40:45+00:00","versionOfRecord":{"articleIdentity":"rs-28826","link":"https://doi.org/10.1007/s12094-020-02399-3","journal":{"identity":"clinical-and-translational-oncology","isVorOnly":false,"title":"Clinical and Translational Oncology"},"publishedOn":"2020-05-29 02:40:45","publishedOnDateReadable":"May 29th, 2020"},"versionCreatedAt":"2020-05-27 21:42:56","video":"","vorDoi":"10.1007/s12094-020-02399-3","vorDoiUrl":"https://doi.org/10.1007/s12094-020-02399-3","workflowStages":[]},"version":"v1","identity":"rs-28826","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-28826","identity":"rs-28826","version":["v1"]},"buildId":"FbvkV6FR0MCFSLy54lSbu","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0